Cornelius P. McCarthy III has reported a transaction involving common stock and restricted stock units in Medpace Holdings, Inc. This filing, dated October 2, 2026, is significant as it shows McCarthy's ongoing engagement with the company and his management of equity holdings.
Background
McCarthy Cornelius P. III is a reporting owner associated with Medpace Holdings, Inc., a company classified under the SIC code for services in commercial physical and biological research. The company is headquartered in Cincinnati, Ohio, and is known for its contributions to the research services industry. Recent filings indicate that McCarthy has been actively managing his stock holdings, with multiple transactions reported over the past months.
What the Filing Says
In the most recent filing, McCarthy disclosed that he acquired 28 shares of common stock on September 30, 2026. Additionally, he reported a transaction involving 28 restricted stock units. The filing states, "Each restricted stock unit represents a contingent right to receive one share of MEDP common stock." Following these transactions, McCarthy now owns a total of 12,303 shares of common stock.
Impact
This update may affect shareholders and potential investors in Medpace Holdings, Inc., as it reflects the company's ongoing equity management strategies. McCarthy's actions could signal confidence in the company's future performance, particularly in the competitive landscape of the commercial research industry.
What's Next
The filing does not say what happens next.